Skip to Content

ipilimumab

 

Definition: A monoclonal antibody targeting CTLA-4 thereby stimulating the activity of cytotoxic T lymphocytes used in the treatment of various neoplasms.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.

Medical Disclaimer

Hide